Genentech, Tercica Prevail In Suit Against Insmed
A California jury awarded $7.5 million plus royalties to biotechnology company Genentech Inc. and its licensee, Tercica Inc, after a "clean sweep" verdict that found a rival start-up infringed its patents...To view the full article, register now.
Already a subscriber? Click here to view full article